Reducing reperfusion injury during percutaneous coronary intervention.
作者信息
Huang Ming-He, Loh Poay Huan, Tan Huay Cheem, Poh Kian Keong
机构信息
Gulf Coast Heart Clinic, Houston, TX, USA.
Department of Cardiology, National University Heart Centre Singapore, National University Health System, Singapore.
出版信息
Singapore Med J. 2019 Dec;60(12):608-609. doi: 10.11622/smedj.2019157.
Abstract
摘要
相似文献
1
Reducing reperfusion injury during percutaneous coronary intervention.经皮冠状动脉介入治疗期间减轻再灌注损伤
Singapore Med J. 2019 Dec;60(12):608-609. doi: 10.11622/smedj.2019157.
2
3
Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment-Elevation Myocardial Infarction.利拉鲁肽对ST段抬高型心肌梗死患者再灌注损伤的影响
Circ Cardiovasc Imaging. 2016 Dec;9(12). doi: 10.1161/CIRCIMAGING.116.005146.
4
B-type natriuretic peptide as a predictor of ischemia/reperfusion injury immediately after myocardial reperfusion in patients with ST-segment elevation acute myocardial infarction.B型利钠肽作为ST段抬高型急性心肌梗死患者心肌再灌注后即刻缺血/再灌注损伤的预测指标。
Eur Heart J Acute Cardiovasc Care. 2016 Feb;5(1):62-70. doi: 10.1177/2048872615568964. Epub 2015 Jan 21.
5
Low-Level Tragus Stimulation for the Treatment of Ischemia and Reperfusion Injury in Patients With ST-Segment Elevation Myocardial Infarction: A Proof-of-Concept Study.低位耳屏刺激治疗 ST 段抬高型心肌梗死患者的缺血再灌注损伤：概念验证研究。
JACC Cardiovasc Interv. 2017 Aug 14;10(15):1511-1520. doi: 10.1016/j.jcin.2017.04.036.
6
Effect of ischemic postconditioning during primary percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction: A single-center cross-sectional study.ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗期间缺血后适应的效果：一项单中心横断面研究。
Ann Card Anaesth. 2019 Oct-Dec;22(4):347-352. doi: 10.4103/aca.ACA_126_18.
7
Female sex is associated with delayed reperfusion by percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.在ST段抬高型心肌梗死患者中，女性性别与经皮冠状动脉介入治疗后再灌注延迟相关。
Pol Arch Med Wewn. 2015;125(6):478-81. doi: 10.20452/pamw.2898. Epub 2015 May 15.
8
Remote ischaemic preconditioning reduces myocardial ischaemic reperfusion injury in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.远程缺血预处理可减轻接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者的心肌缺血再灌注损伤。
Acta Cardiol. 2016;71(5):596-603. doi: 10.2143/AC.71.5.3167504.
9
Promising strategies to minimize reperfusion injury in STEMI.在ST段抬高型心肌梗死中尽量减少再灌注损伤的有前景的策略。
Minerva Cardioangiol. 2016 Jun;64(3):284-94. Epub 2016 Feb 9.
10
Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.血清尿酸水平升高会影响行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者的心肌再灌注和梗死面积。
J Cardiovasc Med (Hagerstown). 2018 May;19(5):240-246. doi: 10.2459/JCM.0000000000000634.
本文引用的文献
1
Beneficial effects of early administration of recombinant human B-type natriuretic peptide in ST-elevation myocardial infarction patients receiving percutaneous coronary intervention treatment.重组人脑利钠肽对行直接经皮冠状动脉介入治疗的急性 ST 段抬高型心肌梗死患者的疗效观察
Singapore Med J. 2019 Dec;60(12):621-625. doi: 10.11622/smedj.2019093. Epub 2019 Aug 7.
2
Editor's Choice- Reperfusion cardiac arrhythmias and their relation to reperfusion-induced cell death.编辑精选- 再灌注性心律失常及其与再灌注诱导的细胞死亡的关系。
Eur Heart J Acute Cardiovasc Care. 2019 Mar;8(2):142-152. doi: 10.1177/2048872618812148. Epub 2018 Nov 13.
3
Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]).早期使用 N-乙酰半胱氨酸联合硝酸盐治疗对行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者的心肌梗死面积的影响（NACIAM 试验[急性心肌梗死后的 N-乙酰半胱氨酸]）。
Circulation. 2017 Sep 5;136(10):894-903. doi: 10.1161/CIRCULATIONAHA.117.027575. Epub 2017 Jun 20.
4
Therapeutic synergy and complementarity for ischemia/reperfusion injury: β1-adrenergic blockade and phosphodiesterase-3 inhibition.缺血/再灌注损伤的治疗协同作用和互补性：β1-肾上腺素能阻断和磷酸二酯酶-3抑制
Int J Cardiol. 2016 Jul 1;214:374-80. doi: 10.1016/j.ijcard.2016.03.200. Epub 2016 Apr 3.
5
Targeted disruption of PDE3B, but not PDE3A, protects murine heart from ischemia/reperfusion injury.特异性破坏磷酸二酯酶3B（PDE3B）而非磷酸二酯酶3A（PDE3A）可保护小鼠心脏免受缺血/再灌注损伤。
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):E2253-62. doi: 10.1073/pnas.1416230112. Epub 2015 Apr 15.
6
Door-to-balloon time and mortality among patients undergoing primary PCI.直接经皮冠状动脉介入治疗患者的门球时间与死亡率。
N Engl J Med. 2013 Sep 5;369(10):901-9. doi: 10.1056/NEJMoa1208200.
7
Myocardial ischemia-reperfusion injury: a neglected therapeutic target.心肌缺血再灌注损伤：一个被忽视的治疗靶点。
J Clin Invest. 2013 Jan;123(1):92-100. doi: 10.1172/JCI62874. Epub 2013 Jan 2.
8
cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology.环磷酸腺苷（cAMP）与环磷酸鸟苷（cGMP）信号转导的相互作用：磷酸二酯酶的作用及其对心脏病理生理学的影响
Circ Res. 2007 Jun 8;100(11):1569-78. doi: 10.1161/CIRCRESAHA.106.144501.
9
Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase.短暂暴露于磷酸二酯酶III抑制剂所提供的心脏保护作用：蛋白激酶A和p38丝裂原活化蛋白激酶的作用。
Circulation. 2001 Aug 7;104(6):705-10. doi: 10.1161/hc3201.092216.
10
Apoptosis in human acute myocardial infarction.人类急性心肌梗死中的细胞凋亡
Circulation. 1997 Jan 21;95(2):320-3. doi: 10.1161/01.cir.95.2.320.
Zotero 插件